<i>XPO1</i> mutations identify early‐stage <scp>CLL</scp> characterized by shorter time to first treatment and enhanced <scp>BCR</scp> signallingRiccardo Moia, Gianluca Gaïdano, Alessio Bruscaggin et al.|British Journal of Haematology|2023Cited by 7
Mutations of the <i>Exportin 1 (XPO1)</i> Gene Predict Shorter Time to First Treatment in 1092 Early Stage Chronic Lymphocytic Leukemia Patients. Α Training/Validation StudyRiccardo Moia, Valter Gattei, Chiara Favini et al.|Blood|2020Cited by 1
P597: XPO1 MUTATIONS IDENTIFY EARLY STAGE CLL CHARACTERIZED BY SHORTER TIME TO FIRST TREATMENT AND ENHANCED BCR SIGNALINGDonatella Talotta, Gianluca Gaïdano, Riccardo Moia et al.|HemaSphere|2023Cited by 0